Memphis Pharmaceuticals stock price and financial data

Issuer profile

Memphis Pharmaceuticals and Chemical Industries SAE is an Egypt-based pharmaceuticals business in the healthcare sector, listed on the Egyptian Exchange under ticker MPCI.CA. Memphis Pharmaceuticals and Chemical Industries SAE (MPCI), a member of Holding Company for Pharmaceuticals (Holdipharma), is an Egypt-based public shareholding company engaged in the research and development, manufacture, trade, marketing and distribution of pharmaceutical products for human and veterinary use. Memphis Pharmaceuticals and Chemical Industries SAE produces a range of products, including Effervescent, Syrups, Creams, Tablets, Capsules, Injections and Suppositories. Memphis Pharmaceuticals and Chemical Industries SAE is characterized by its production of ampoules, extracts and active principles from medicinal plants. Memphis Pharmaceuticals and Chemical Industries SAE exports its products to Asian and European countries, the United States and Canada. Its investment profile is best assessed through product quality, regulatory compliance, distribution, pricing, and demand from Egypt’s healthcare market. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.